CELL INTELLIGENCE · 肿瘤细胞治疗研究

CAR 在非 B 细胞恶性肿瘤中停滞了吗？我们身处何处，又将去向何方？

Have CARs stalled for non-B-cell malignancies? Where are we, and where are we going?

用于肿瘤免疫治疗的体外自体造血干细胞来源 T 淋巴细胞的生成

Generation of ex vivo autologous hematopoietic stem cell-derived T lymphocytes for cancer immunotherapy.

多色流式细胞术检测供者来源 allo-HSCT 受者微小残留病的异常：一项队列研究

Abnormalities by Multicolor Flow Cytometry for Detection of Minimal Residual Disease in Recipients of Allo-HSCT Originating from Donors: A Cohort Stud

通过 MRD 分析检测到的 allo-HSCT 受者异常可能来源于其供者。